A Pilot Study of the Treatment of Central Serous Chorioretinopathy With Ketoconazole

NCT00211393 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Chronic Central Serous Chorioretinopathy

Interventions

DRUG: ketoconazole

Sponsor

Manhattan Eye, Ear & Throat Hospital

Collaborators

[object Object]